Do you need more information?
The COVID-19 pandemic is an ongoing, unprecedented global health challenge.
bioMérieux is proud to be a part of the global response with the development of three of the first commercially available diagnostic tests for SARS-CoV-2, along with additional critical tests for COVID-19 patients management.
Every COVID-19 patient comes with a unique profile and experiences the disease differently. Patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.
Do you need more information?
Patients with suspected COVID-19 present with a broad array of symptoms – many of which can also be caused by other diseases. Additionally, patients with serious COVID-19 infections frequently experience secondary opportunistic infections.
COVID-19 patient management requires the healthcare team to be alert to the patient’s varied needs from primary diagnosis to the recovery period.
Throughout the patient pathway, diagnostic tests provide vital information to support improved patient care decision-making.
PRIMARY DIAGNOSIS |
||
|
|
COVID-19 R-GENE® SARS-COV-2 RESPI R-GENE® [4] and EMAG® [5] |
Real-time PCR test that can be run on most commercial PCR platforms CE-IVD |
|
|
BIOFIRE® Respiratory 2.1 Panel (RP2.1) [7]* BIOFIRE® Respiratory 2.1 [7]plus [7]Panel [7] ( [7]RP2.1 [7]plus) [7]** |
Includes SARS-CoV-2 plus 21 (22 for RP2.1plus) other common respiratory pathogens, for use on BIOFIRE® FILMARRAY® platforms * US FDA De Novo Authorization ** CE-IVD |
|
|
and VIDAS® SARS-COV2-IgGII [9] |
Serological tests that run on VIDAS® platforms. Three assays to better follow antibody responses. Assays for the detection of immunoglobulin IgG and IgM specific for the SARS‑CoV‑2 receptor-binding domain (RBD) of the spike protein in human serum or plasma and assessment of the level of IgG anti-SARS-CoV-2 antibodies CE-IVD |
SEVERITY ASSESSMENT |
|
|
VIDAS® D-Dimer Exclusion™ II [11] VIDAS® High Sensitive Troponin I [12] VIDAS® NT-proBNP2 [13] |
Inflammation, coagulation and cardiac biomarkers |
| NEPHROCHECK® [15] |
Acute Kidney Injury biomarker |
IDENTIFY POTENTIAL CO-INFECTIONS AND SECONDARY INFECTIONS |
|
| VIDAS® B·R·A·H·M·S PCT™ [10] |
Specific biomarker of severe bacterial infection and sepsis |
| BACT/ALERT® [16] |
Family of automated microbial detection systems and blood culture media |
|
BIOFIRE® RP2.1 / RP2.1 [7]plus [7] Panel [7] |
Multiplex PCR for detection of respiratory tract infections (virus, bacteria) |
| BIOFIRE® [17]PN/P [17]N [17]plus [17] [17]Panel [17] |
Multiplex PCR for detection of lower respiratory tract infections (virus, bacteria, antimicrobial resistance genes) |
| PREVI® COLOR GRAM [18] |
Automated Gram staining |
| VITEK® MS PRIME [19] |
Mass spectrometry for identification of pathogens |
|
Respiratory R-GENE® [4]tests [4] and EMAG [5]® [5] & NUCLISENS® extraction reagents [5] |
A range of real-time PCR kits for accurate simultaneous detection of infectious agents involved in respiratory diseases |
| CHROMID® chromogenic media [20] |
Chromogenic media for growth and identification of pathogens |
ANTIMICROBIAL TREATMENT SELECTION AND MONITORINGFor potential co-infections and secondary infections |
|
| VIDAS® B·R·A·H·M·S PCT™ [10] |
Specific biomarker of severe bacterial infection and sepsis |
| VITEK® 2 [21] |
Microbial identification and Antimicrobial susceptibility testing |
| ETEST® [22] |
MIC for challenging situations |
OUTCOME ASSESSMENT / DISCHARGE / FOLLOW-UP |
|
| COVID-19 R-GENE® SARS-COV-2 RESPI R-GENE® , EMAG® and NUCLISENS® extraction reagents [4] | |
| VIDAS® SARS-COV-2 IgM, SARS-COV-2 IgG, and SARS-COV2-IgGII [9] |
Availability of products range is subject to local regulatory approvals, allocation priorities, supply chain policies etc. Please check with your local bioMérieux representative to know more.
DOWNLOAD THE GUIDE : DIAGNOSTIC TOOLS FOR THE MANAGEMENT OF COVID-19 PATIENTS [23]
Fascinating insights from experts around the worldbioMérieux is committed to support high quality medical education for the ultimate benefits of patients.
Head to our Medical Affairs page [24] for our series of webinars featuring experts from around the world on SARS-CoV-2 and COVID-19.
From various specialities, they share insights, lines of investigation, emerging questions and potential solutions.
|
Multiplex PCR for detection of upper and lower respiratory tract infections (virus, bacteria, antimicrobial resistance genes) |
[21]
[26]
[10]
[27]
[28]
[29]
[7]
[30]
Links
[1] https://www.biomerieux-diagnostics.com/contact?pdt=1249
[2] https://www.biomerieux-diagnostics.com/sites/clinic/files/r-gene.png
[3] https://www.biomerieux-diagnostics.com/sites/clinic/files/argene_covid-19_solutions_ce_marked_-_9321502_007-gb-a_3_0.pdf
[4] https://www.biomerieux-diagnostics.com/sars-cov-2-r-gene
[5] https://www.biomerieux-diagnostics.com/nuclisensr-easymagr
[6] https://www.biomerieux-diagnostics.com/sites/clinic/files/cim_pamphlet_rp2.1plus.pdf
[7] https://www.biomerieux-diagnostics.com/filmarrayr-respiratory-panel
[8] https://www.biomerieux-diagnostics.com/sites/clinic/files/vidas_sars_cov-2_brochure.pdf
[9] https://www.biomerieux-diagnostics.com/vidas-sars-cov-2
[10] https://www.biomerieux-diagnostics.com/vidasr-brahms-pct
[11] https://www.biomerieux-diagnostics.com/vidasr-d-dimer-exclusion-ii
[12] https://www.biomerieux-diagnostics.com/vidasr-high-sensitive-troponin-i
[13] https://www.biomerieux-diagnostics.com/vidasr-nt-probnp2-0
[14] https://www.biomerieux-diagnostics.com/vidasr-ferritin
[15] https://www.biomerieux-diagnostics.com/nephrocheck-test-acute-kidney-injury
[16] https://www.biomerieux-diagnostics.com/bact-alert-culture-media
[17] https://www.biomerieux-diagnostics.com/biofire-filmarray-pneumonia-plus-panel
[18] https://www.biomerieux-diagnostics.com/previr-color-gram
[19] https://www.biomerieux-diagnostics.com/vitekr-ms-0
[20] https://www.biomerieux-diagnostics.com/chromid-range
[21] https://www.biomerieux-diagnostics.com/vitekr-2-0
[22] https://www.biomerieux-diagnostics.com/etestr
[23] https://www.biomerieux-diagnostics.com/sites/clinic/files/clinical_utility_of_biomerieux_solutions_for_covid-19_patients.pdf
[24] https://www.biomerieux.com/en/education/covid-19/webinars
[25] https://www.biomerieux-diagnostics.com/javascript%3Avoid%280%29
[26] https://www.biomerieux-diagnostics.com/vitekr-ms-accessories-reagents
[27] https://www.biomerieux-diagnostics.com/chromidr-esbl
[28] https://www.biomerieux-diagnostics.com/nuclisens-easyqr
[29] https://www.biomerieux-diagnostics.com/biofire-bcid2-panel
[30] https://www.biomerieux-diagnostics.com/filmarrayr-gi-panel
